Report cover image

Global Piroxicam Oral Tablets Industry Growth and Trends Forecast to 2031

Publisher APO Research, Inc.
Published Jul 07, 2025
Length 98 Pages
SKU # APRC20338884

Description

Summary

According to APO Research, The global Piroxicam Oral Tablets market was estimated at US$ million in 2025 and is projected to reach a revised size of US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2026-2031.

North American market for Piroxicam Oral Tablets is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Asia-Pacific market for Piroxicam Oral Tablets is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Europe market for Piroxicam Oral Tablets is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

The major global manufacturers of Piroxicam Oral Tablets include Yunpeng Pharmaceutical Group, Shandong Fangming Pharmaceutical Group, Wanrong Pharmaceutical (Langzhi Group), Nantong Jinghua Pharmaceutical, Wellona Pharma, SK Chemical, Pfizer, Chr. Olesen Group and Adva Care Pharma, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Piroxicam Oral Tablets, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Piroxicam Oral Tablets.

The Piroxicam Oral Tablets market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Piroxicam Oral Tablets market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.

Piroxicam Oral Tablets Segment by Company

Yunpeng Pharmaceutical Group
Shandong Fangming Pharmaceutical Group
Wanrong Pharmaceutical (Langzhi Group)
Nantong Jinghua Pharmaceutical
Wellona Pharma
SK Chemical
Pfizer
Chr. Olesen Group
Adva Care Pharma
Piroxicam Oral Tablets Segment by Type

Regular Release Tablets
Modified Release Tablets
Piroxicam Oral Tablets Segment by Application

Hospital
Clinic
Pharmacy
Piroxicam Oral Tablets Segment by Region

North America

United States
Canada
Mexico
Europe

Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific

China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America

Brazil
Argentina
Chile
Colombia
Middle East & Africa

Egypt
South Africa
Israel
Türkiye
GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Piroxicam Oral Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Piroxicam Oral Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Piroxicam Oral Tablets.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Piroxicam Oral Tablets manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Piroxicam Oral Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

98 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Piroxicam Oral Tablets Market Size Estimates and Forecasts (2020-2031)
1.2.2 Global Piroxicam Oral Tablets Sales Estimates and Forecasts (2020-2031)
1.3 Piroxicam Oral Tablets Market by Type
1.3.1 Regular Release Tablets
1.3.2 Modified Release Tablets
1.4 Global Piroxicam Oral Tablets Market Size by Type
1.4.1 Global Piroxicam Oral Tablets Market Size Overview by Type (2020-2031)
1.4.2 Global Piroxicam Oral Tablets Historic Market Size Review by Type (2020-2025)
1.4.3 Global Piroxicam Oral Tablets Forecasted Market Size by Type (2026-2031)
1.5 Key Regions Market Size by Type
1.5.1 North America Piroxicam Oral Tablets Sales Breakdown by Type (2020-2025)
1.5.2 Europe Piroxicam Oral Tablets Sales Breakdown by Type (2020-2025)
1.5.3 Asia-Pacific Piroxicam Oral Tablets Sales Breakdown by Type (2020-2025)
1.5.4 South America Piroxicam Oral Tablets Sales Breakdown by Type (2020-2025)
1.5.5 Middle East and Africa Piroxicam Oral Tablets Sales Breakdown by Type (2020-2025)
2 Global Market Dynamics
2.1 Piroxicam Oral Tablets Industry Trends
2.2 Piroxicam Oral Tablets Industry Drivers
2.3 Piroxicam Oral Tablets Industry Opportunities and Challenges
2.4 Piroxicam Oral Tablets Industry Restraints
3 Market Competitive Landscape by Company
3.1 Global Top Players by Piroxicam Oral Tablets Revenue (2020-2025)
3.2 Global Top Players by Piroxicam Oral Tablets Sales (2020-2025)
3.3 Global Top Players by Piroxicam Oral Tablets Price (2020-2025)
3.4 Global Piroxicam Oral Tablets Industry Company Ranking, 2023 VS 2024 VS 2025
3.5 Global Piroxicam Oral Tablets Major Company Production Sites & Headquarters
3.6 Global Piroxicam Oral Tablets Company, Product Type & Application
3.7 Global Piroxicam Oral Tablets Company Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Piroxicam Oral Tablets Market CR5 and HHI
3.8.2 Global Top 5 and 10 Piroxicam Oral Tablets Players Market Share by Revenue in 2024
3.8.3 2023 Piroxicam Oral Tablets Tier 1, Tier 2, and Tier 3
4 Piroxicam Oral Tablets Regional Status and Outlook
4.1 Global Piroxicam Oral Tablets Market Size and CAGR by Region: 2020 VS 2024 VS 2031
4.2 Global Piroxicam Oral Tablets Historic Market Size by Region
4.2.1 Global Piroxicam Oral Tablets Sales in Volume by Region (2020-2025)
4.2.2 Global Piroxicam Oral Tablets Sales in Value by Region (2020-2025)
4.2.3 Global Piroxicam Oral Tablets Sales (Volume & Value), Price and Gross Margin (2020-2025)
4.3 Global Piroxicam Oral Tablets Forecasted Market Size by Region
4.3.1 Global Piroxicam Oral Tablets Sales in Volume by Region (2026-2031)
4.3.2 Global Piroxicam Oral Tablets Sales in Value by Region (2026-2031)
4.3.3 Global Piroxicam Oral Tablets Sales (Volume & Value), Price and Gross Margin (2026-2031)
5 Piroxicam Oral Tablets by Application
5.1 Piroxicam Oral Tablets Market by Application
5.1.1 Hospital
5.1.2 Clinic
5.1.3 Pharmacy
5.2 Global Piroxicam Oral Tablets Market Size by Application
5.2.1 Global Piroxicam Oral Tablets Market Size Overview by Application (2020-2031)
5.2.2 Global Piroxicam Oral Tablets Historic Market Size Review by Application (2020-2025)
5.2.3 Global Piroxicam Oral Tablets Forecasted Market Size by Application (2026-2031)
5.3 Key Regions Market Size by Application
5.3.1 North America Piroxicam Oral Tablets Sales Breakdown by Application (2020-2025)
5.3.2 Europe Piroxicam Oral Tablets Sales Breakdown by Application (2020-2025)
5.3.3 Asia-Pacific Piroxicam Oral Tablets Sales Breakdown by Application (2020-2025)
5.3.4 South America Piroxicam Oral Tablets Sales Breakdown by Application (2020-2025)
5.3.5 Middle East and Africa Piroxicam Oral Tablets Sales Breakdown by Application (2020-2025)
6 Company Profiles
6.1 Yunpeng Pharmaceutical Group
6.1.1 Yunpeng Pharmaceutical Group Comapny Information
6.1.2 Yunpeng Pharmaceutical Group Business Overview
6.1.3 Yunpeng Pharmaceutical Group Piroxicam Oral Tablets Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Yunpeng Pharmaceutical Group Piroxicam Oral Tablets Product Portfolio
6.1.5 Yunpeng Pharmaceutical Group Recent Developments
6.2 Shandong Fangming Pharmaceutical Group
6.2.1 Shandong Fangming Pharmaceutical Group Comapny Information
6.2.2 Shandong Fangming Pharmaceutical Group Business Overview
6.2.3 Shandong Fangming Pharmaceutical Group Piroxicam Oral Tablets Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Shandong Fangming Pharmaceutical Group Piroxicam Oral Tablets Product Portfolio
6.2.5 Shandong Fangming Pharmaceutical Group Recent Developments
6.3 Wanrong Pharmaceutical (Langzhi Group)
6.3.1 Wanrong Pharmaceutical (Langzhi Group) Comapny Information
6.3.2 Wanrong Pharmaceutical (Langzhi Group) Business Overview
6.3.3 Wanrong Pharmaceutical (Langzhi Group) Piroxicam Oral Tablets Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Wanrong Pharmaceutical (Langzhi Group) Piroxicam Oral Tablets Product Portfolio
6.3.5 Wanrong Pharmaceutical (Langzhi Group) Recent Developments
6.4 Nantong Jinghua Pharmaceutical
6.4.1 Nantong Jinghua Pharmaceutical Comapny Information
6.4.2 Nantong Jinghua Pharmaceutical Business Overview
6.4.3 Nantong Jinghua Pharmaceutical Piroxicam Oral Tablets Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Nantong Jinghua Pharmaceutical Piroxicam Oral Tablets Product Portfolio
6.4.5 Nantong Jinghua Pharmaceutical Recent Developments
6.5 Wellona Pharma
6.5.1 Wellona Pharma Comapny Information
6.5.2 Wellona Pharma Business Overview
6.5.3 Wellona Pharma Piroxicam Oral Tablets Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Wellona Pharma Piroxicam Oral Tablets Product Portfolio
6.5.5 Wellona Pharma Recent Developments
6.6 SK Chemical
6.6.1 SK Chemical Comapny Information
6.6.2 SK Chemical Business Overview
6.6.3 SK Chemical Piroxicam Oral Tablets Sales, Revenue and Gross Margin (2020-2025)
6.6.4 SK Chemical Piroxicam Oral Tablets Product Portfolio
6.6.5 SK Chemical Recent Developments
6.7 Pfizer
6.7.1 Pfizer Comapny Information
6.7.2 Pfizer Business Overview
6.7.3 Pfizer Piroxicam Oral Tablets Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Pfizer Piroxicam Oral Tablets Product Portfolio
6.7.5 Pfizer Recent Developments
6.8 Chr. Olesen Group
6.8.1 Chr. Olesen Group Comapny Information
6.8.2 Chr. Olesen Group Business Overview
6.8.3 Chr. Olesen Group Piroxicam Oral Tablets Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Chr. Olesen Group Piroxicam Oral Tablets Product Portfolio
6.8.5 Chr. Olesen Group Recent Developments
6.9 Adva Care Pharma
6.9.1 Adva Care Pharma Comapny Information
6.9.2 Adva Care Pharma Business Overview
6.9.3 Adva Care Pharma Piroxicam Oral Tablets Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Adva Care Pharma Piroxicam Oral Tablets Product Portfolio
6.9.5 Adva Care Pharma Recent Developments
7 North America by Country
7.1 North America Piroxicam Oral Tablets Sales by Country
7.1.1 North America Piroxicam Oral Tablets Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.1.2 North America Piroxicam Oral Tablets Sales by Country (2020-2025)
7.1.3 North America Piroxicam Oral Tablets Sales Forecast by Country (2026-2031)
7.2 North America Piroxicam Oral Tablets Market Size by Country
7.2.1 North America Piroxicam Oral Tablets Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.2.2 North America Piroxicam Oral Tablets Market Size by Country (2020-2025)
7.2.3 North America Piroxicam Oral Tablets Market Size Forecast by Country (2026-2031)
8 Europe by Country
8.1 Europe Piroxicam Oral Tablets Sales by Country
8.1.1 Europe Piroxicam Oral Tablets Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.1.2 Europe Piroxicam Oral Tablets Sales by Country (2020-2025)
8.1.3 Europe Piroxicam Oral Tablets Sales Forecast by Country (2026-2031)
8.2 Europe Piroxicam Oral Tablets Market Size by Country
8.2.1 Europe Piroxicam Oral Tablets Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.2.2 Europe Piroxicam Oral Tablets Market Size by Country (2020-2025)
8.2.3 Europe Piroxicam Oral Tablets Market Size Forecast by Country (2026-2031)
9 Asia-Pacific by Country
9.1 Asia-Pacific Piroxicam Oral Tablets Sales by Country
9.1.1 Asia-Pacific Piroxicam Oral Tablets Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.1.2 Asia-Pacific Piroxicam Oral Tablets Sales by Country (2020-2025)
9.1.3 Asia-Pacific Piroxicam Oral Tablets Sales Forecast by Country (2026-2031)
9.2 Asia-Pacific Piroxicam Oral Tablets Market Size by Country
9.2.1 Asia-Pacific Piroxicam Oral Tablets Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.2.2 Asia-Pacific Piroxicam Oral Tablets Market Size by Country (2020-2025)
9.2.3 Asia-Pacific Piroxicam Oral Tablets Market Size Forecast by Country (2026-2031)
10 South America by Country
10.1 South America Piroxicam Oral Tablets Sales by Country
10.1.1 South America Piroxicam Oral Tablets Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.1.2 South America Piroxicam Oral Tablets Sales by Country (2020-2025)
10.1.3 South America Piroxicam Oral Tablets Sales Forecast by Country (2026-2031)
10.2 South America Piroxicam Oral Tablets Market Size by Country
10.2.1 South America Piroxicam Oral Tablets Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.2.2 South America Piroxicam Oral Tablets Market Size by Country (2020-2025)
10.2.3 South America Piroxicam Oral Tablets Market Size Forecast by Country (2026-2031)
11 Middle East and Africa by Country
11.1 Middle East and Africa Piroxicam Oral Tablets Sales by Country
11.1.1 Middle East and Africa Piroxicam Oral Tablets Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.1.2 Middle East and Africa Piroxicam Oral Tablets Sales by Country (2020-2025)
11.1.3 Middle East and Africa Piroxicam Oral Tablets Sales Forecast by Country (2026-2031)
11.2 Middle East and Africa Piroxicam Oral Tablets Market Size by Country
11.2.1 Middle East and Africa Piroxicam Oral Tablets Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.2.2 Middle East and Africa Piroxicam Oral Tablets Market Size by Country (2020-2025)
11.2.3 Middle East and Africa Piroxicam Oral Tablets Market Size Forecast by Country (2026-2031)
12 Value Chain and Sales Channels Analysis
12.1 Piroxicam Oral Tablets Value Chain Analysis
12.1.1 Piroxicam Oral Tablets Key Raw Materials
12.1.2 Key Raw Materials Price
12.1.3 Raw Materials Key Suppliers
12.1.4 Manufacturing Cost Structure
12.1.5 Piroxicam Oral Tablets Production Mode & Process
12.2 Piroxicam Oral Tablets Sales Channels Analysis
12.2.1 Direct Comparison with Distribution Share
12.2.2 Piroxicam Oral Tablets Distributors
12.2.3 Piroxicam Oral Tablets Customers
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.